Gara Jalqabaatti › Dhibee Seli Sikiilii › Alabama › Birmingham
Qorannoo klinikaalii Dhibee Seli Sikiilii Birmingham, AL keessatti
Qorannoo 14 Dhibee Seli Sikiilii f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Namoota walitti qabaa jiraSadarkaa 1
- University of Alabama at Birmingham, Birmingham
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Namoota walitti qabaa jiraSadarkaa 3
- University Of Alabama, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Namoota walitti qabaa jiraSadarkaa 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Namoota walitti qabaa jiraSadarkaa 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Namoota walitti qabaa jira
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Namoota walitti qabaa jiraSadarkaa 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
Namoota walitti qabaa jiraSadarkaa 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Alabama, Birmingham (UAB), Birmingham
Qorannoo Dhibee Seli Sikiilii magaalota biroo keessatti
- Atlanta, GAQorannoo 22
- Washington, DCQorannoo 20
- Chicago, ILQorannoo 18
- Memphis, TNQorannoo 18
- Philadelphia, PAQorannoo 15
- New York City, NYQorannoo 13
- St. Louis, MOQorannoo 12
- Boston, MAQorannoo 10
- Durham, NCQorannoo 10
- Houston, TXQorannoo 10
- Cincinnati, OHQorannoo 10
- Greenville, NCQorannoo 9
Qorannoo biroo Birmingham keessatti
- Saree (Gosoota Hunda)Qorannoo 31
- Saree OljooQorannoo 24
- Kansarii OvariiQorannoo 23
- ObesityQorannoo 23
- Kansara Qara'a Non-Small CellQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 21
- Myeloma Baay’eeQorannoo 18
- COPDQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 17
- Sukkaraa Gosa 2Qorannoo 16
- Kansa EndometiriyaaliiQorannoo 16
- Baayyee UlfaataaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.